Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Remimazolam on Emergence Delirium in Pediatrics Undergoing Neurosurgery With Sevoflurane Anesthesia

NCT07046364 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT07046364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07046364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Remimazolam on Emergence Delirium in Pediatrics Undergoing Neurosurgery With Sevoflurane Anesthesia
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
January 1, 2025
Completion date
January 1, 2027
Enrollment
248 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

emergence delirium, neurosurgery, pediatric, remimazolam, sevoflurane anesthesia